Corrigendum to Substitutions at residue 211 in the prion protein drive a switch between CJD and GSS syndrome, a new mechanism governing inherited neurodegenerative disorders [Human Molecular Genetics, 21, 26, (2012), 5417-5428] DOI: 10.1093/hmg/dds377;Substitutions at residue 211 in the prion protein drive a switch between CJD and GSS syndrome, a new mechanism governing inherited neurodegenerative disorders

Human Molecular Genetics

Volumn 21, Issue 26, 2012, Pages 5417-5428

  Peoc'h, Katell ^a,b,c   Levavasseur, Etienne ^c,d,e,f   Delmont, Emilien ^g   De simone, Alfonso ^h   Laffont proust, Isabelle ^c,d,e,f   Privat, Nicolas ^c,d,e,f   Chebaro, Yassmine ⁱ   Chapuis, Céline ^j   Bedoucha, Pierre ^g   Brandel, Jean Philippe ^c,d,e,f,k   Laquerriere, Annie ^l   Kemeny, Jean Louis ^m   Hauw, Jean Jacques ^a,c,d,e,f   Borg, Michel ⁿ   Rezaei, Human ^j   Derreumaux, Philippe ⁱ   Laplanche, Jean Louis ^a,b,c   Haïk, Stéphane ^a,c,d,e,f,k  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b FACULTÉ DES SCIENCES PHARMACEUTIQUES ET BIOLOGIQUES   (France)

^c Centre National de Référence des Agents Transmissibles Non Conventionnels InVS   (France)

^d SORBONNE UNIVERSITÉ   (France)

^e INSERM   (France)

^f CNRS   (France)

^g Centre référent en Pathologies Neuromusculaires et SLA   (France)

^h UNIVERSITY OF CAMBRIDGE   (United Kingdom)

ⁱ INST DE BIOLOGIE PHYSICO CHIMIQUE   (France)

^j CEMAGREF   (France)

^k PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^l ROUEN UNIVERSITY HOSPITAL   (France)

^m SERVICE DE RHUMATOLOGIE   (France)

ⁿ PASTEUR HOSPITAL   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

PRION PROTEIN; PROTEINASE; TAU PROTEIN;

AMINO ACID SUBSTITUTION; AMYLOID PLAQUE; ARTICLE; BIOPHYSICS; CHEMICAL ANALYSIS; CLINICAL FEATURE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; DEGENERATIVE DISEASE; GENE SWITCHING; GENETIC DISORDER; GENETIC VARIABILITY; GERSTMANN STRAUSSLER SCHEINKER SYNDROME; HUMAN; HUMAN TISSUE; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; NEUROFIBRILLARY TANGLE; NEUROFILAMENT; NEUROPATHOLOGY; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FOLDING;

EID: 84870795501     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddt654     Document Type: Erratum

References (50)

1. Prusiner, S.B. (1998) Prions. Proc. Natl Acad. Sci. USA, 95, 13363-13383.
2. Prusiner, S.B. (1982) Novel proteinaceous infectious particles cause scrapie. Science, 216, 136-144.
3. Weissmann, C. (2004) The state of the prion. Nat. Rev. Microbiol., 2, 861-871.
4. Aguzzi, A., Baumann, F. and Bremer, J. (2008) The prion's elusive reason for being. Annu. Rev. Neurosci., 31, 439-477.
5. Owen, F., Poulter, M., Lofthouse, R., Collinge, J., Crow, T.J., Risby, D., Baker, H.F., Ridley, R.M., Hsiao, K. and Prusiner, S.B. (1989) Insertion in prion protein gene in familial Creutzfeldt-Jakob disease. Lancet, 1, 51-52.
6. Goldfarb, L.G., Mitrova, E., Brown, P., Toh, B.H. and Gajdusek, D.C. (1990) Mutation in codon 200 of scrapie amyloid protein gene in two clusters of Creutzfeldt-Jakob disease in Slovakia. Lancet, 336, 514-515.
7. Hsiao, K., Baker, H.F., Crow, T.J., Poulter, M., Owen, F., Terwilliger, J.D., Westaway, D., Ott, J. and Prusiner, S.B. (1989) Linkage of a prion protein missense variant to Gerstmann-Straussler syndrome. Nature, 338, 342-345.
8. Medori, R., Tritschler, H.J., Leblanc, A., Villare, F., Manetto, V., Chen, H.Y., Xue, R., Leal, S., Montagna, P., Cortelli, P. et al. (1992) Fatal familial insomnia, a prion disease with a mutation at codon-178 of the prion protein gene. N. Engl. J. Med., 326, 444-449.
9. Goldfarb, L.G., Brown, P., Mccombie, W.R., Goldgaber, D., Swergold, G.D., Wills, P.R., Cervenakova, L., Baron, H., Gibbs, C.J. and Gajdusek, D.C. (1991) Transmissible familial Creutzfeldt-Jakob disease associated with five, seven, and eight extra octapeptide coding repeats in the PRNP gene. Proc. Natl Acad. Sci. USA, 88, 10926-10930.
10. Goldfarb, L.G., Petersen, R.B., Tabaton, M., Brown, P., LeBlanc, A.C., Montagna, P., Cortelli, P., Julien, J., Vital, C., Pendelbury, W.W. et al. (1992) Fatal familial insomnia and familial Creutzfeldt-Jakob disease: disease phenotype determined by a DNA polymorphism. Science, 258, 806-808.
11. Ghetti, B., Dlouhy, S.R., Giaccone, G., Bugiani, O., Frangione, B., Farlow, M.R. and Tagliavini, F. (1995) Gerstmann-Straussler-Scheinker disease and the Indiana kindred. Brain Pathol., 5, 61-75.
12. Puoti, G., Giaccone, G., Rossi, G., Canciani, B., Bugiani, O. and Tagliavini, F. (1999) Sporadic Creutzfeldt-Jakob disease: co-occurrence of different types of PrP(Sc) in the same brain. Neurology, 53, 2173-2176.
13. Haik, S., Peoc'h, K., Brandel, J.P., Privat, N., Laplanche, J.L., Faucheux, B.A. and Hauw, J.J. (2004) Striking PrPsc heterogeneity in inherited prion diseases with the D178N mutation. Ann. Neurol., 56, 909-910.
14. Schoch, G., Seeger, H., Bogousslavsky, J., Tolnay, M., Janzer, R.C., Aguzzi, A. and Glatzel, M. (2006) Analysis of prion strains by PrPSc profiling in sporadic Creutzfeldt-Jakob disease. PLoS Med., 3, e14.
15. Cali, I., Castellani, R., Alshekhlee, A., Cohen, Y., Blevins, J., Yuan, J., Langeveld, J.P., Parchi, P., Safar, J.G., Zou, W.Q. et al. (2009) Co-existence of scrapie prion protein types 1 and 2 in sporadic Creutzfeldt-Jakob disease: its effect on the phenotype and prion-type characteristics. Brain, 132, 2643-2658.
16. Parchi, P., Chen, S.G., Brown, P., Zou, W., Capellari, S., Budka, H., Hainfellner, J., Reyes, P.F., Golden, G.T., Hauw, J.J. et al. (1998) Different patterns of truncated prion protein fragments correlate with distinct phenotypes in P102L Gerstmann-Straussler-Scheinker disease. Proc. Natl Acad. Sci. USA, 95, 8322-8327.
17. Tagliavini, F., Lievens, P.M., Tranchant, C., Warter, J.M., Mohr, M., Giaccone, G., Perini, F., Rossi, G., Salmona, M., Piccardo, P. et al. (2001) A 7-kDa prion protein (PrP) fragment, an integral component of the PrP region required for infectivity, is the major amyloid protein in Gerstmann-Straussler-Scheinker disease A117V. J. Biol. Chem., 276, 6009-6015.
18. Rezaei, H., Eghiaian, F., Perez, J., Doublet, B., Choiset, Y., Haertle, T. and Grosclaude, J. (2005) Sequential generation of two structurally distinct ovine prion protein soluble oligomers displaying different biochemical reactivities. J. Mol. Biol., 347, 665-679.
19. Eghiaian, F., Daubenfeld, T., Quenet, Y., van Audenhaege, M., Bouin, A.P., van der Rest, G., Grosclaude, J. and Rezaei, H. (2007) Diversity in prion protein oligomerization pathways results from domain expansion as revealed by hydrogen/deuterium exchange and disulfide linkage. Proc. Natl Acad. Sci. USA, 104, 7414-7419.
20. Saborio, G.P., Permanne, B. and Soto, C. (2001) Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature, 411, 810-813.
21. Chen, B., Morales, R., Barria, M.A. and Soto, C. (2010) Estimating prion concentration in fluids and tissues by quantitative PMCA. Nat. Methods, 7, 519-520.
22. Castilla, J., Saa, P., Hetz, C. and Soto, C. (2005) In vitro generation of infectious scrapie prions. Cell, 121, 195-206.
23. Jones, M., Peden, A.H., Prowse, C.V., Groner, A., Manson, J.C., Turner, M.L., Ironside, J.W., MacGregor, I.R. and Head, M.W. (2007) In vitro amplification and detection of variant Creutzfeldt-Jakob disease PrPSc. J. Pathol., 213, 21-26.
24. Jones, M., Peden, A.H., Wight, D., Prowse, C., Macgregor, I., Manson, J., Turner, M., Ironside, J.W. and Head, M.W. (2008) Effects of human PrPSc type and PRNP genotype in an in-vitro conversion assay. Neuroreport, 19, 1783-1786.
25. Castilla, J., Gonzalez-Romero, D., Saa, P., Morales, R., De Castro, J. and Soto, C. (2008) Crossing the species barrier by PrP(Sc) replication in vitro generates unique infectious prions. Cell, 134, 757-768.
26. Jones, M., Wight, D., Barron, R., Jeffrey, M., Manson, J., Prowse, C., Ironside, J.W. and Head, M.W. (2009) Molecular model of prion transmission to humans. Emerg. Infect. Dis., 15, 2013-2016.
27. Castilla, J., Morales, R., Saa, P., Barria, M., Gambetti, P. and Soto, C. (2008) Cell-free propagation of prion strains. EMBO J., 27, 2557-2566.
28. Palmer, M.S., Dryden, A.J., Hughes, J.T. and Collinge, J. (1991) Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease. Nature, 352, 340-342.
29. Laplanche, J.L., Delasnerie-Lauprê tre, N., Brandel, J.P., Chatelain, J., Beaudry, P., Alpérovitch, A. and Launay, J.M. (1994) Molecular genetics of prion diseases in France. Neurology, 44, 2347-2351.
30. Kovacs, G.G., Puopolo, M., Ladogana, A., Pocchiari, M., Budka, H., van Duijn, C., Collins, S.J., Boyd, A., Giulivi, A., Coulthart, M. et al. (2005) Genetic prion disease: the EUROCJD experience. Hum. Genet., 118, 166-174.
31. Peoc'h, K., Manivet, P., Beaudry, P., Attane, F., Besson, G., Hannequin, D., Delasnerie-Laupretre, N. and Laplanche, J.L. (2000) Identification of three novel mutations (E196K, V203I, E211Q) in the prion protein gene (PRNP) in inherited prion diseases with Creutzfeldt-Jakob disease phenotype. Hum. Mutat., 15, 482.
32. Ladogana, A., Almonti, S., Petraroli, R., Giaccaglini, E., Ciarmatori, C., Liu, Q.G., Bevivino, S., Squitieri, F. and Pocchiari, M. (2001) Mutation of the PRNP gene at codon 211 in familial Creutzfeldt-Jakob disease. Am. J. Med. Genet., 103, 133-137.
33. Zahn, R., Liu, A., Luhrs, T., Riek, R., von Schroetter, C., Lopez Garcia, F., Billeter, M., Calzolai, L., Wider, G. and Wuthrich, K. (2000) NMR solution structure of the human prion protein. Proc. Natl Acad. Sci. USA, 97, 145-150.
34. Kitamoto, T., Ohta, M., Dohura, K., Hitoshi, S., Terao, Y. and Tateishi, J. (1993) Novel missense variants of prion protein in Creutzfeldt-Jakob disease or Gerstmann-Straussler syndrome. Biochem. Biophys. Res. Commun., 191, 709-714.
35. Bratosiewicz, J., Barcikowska, M., Cervenakowa, L., Brown, P., Gajdusek, D.C. and Liberski, P.P. (2000) A new point mutation of the PRNP gene in Gerstmann-Straussler-Scheinker case in Poland. Folia Neuropathol., 38, 164-166.
36. Beck, J., Collinge, J. and Mead, S. (2012) Prion protein gene M232R variation is probably an uncommon polymorphism rather than a pathogenic mutation. Brain, 135, e209; author reply e210.
37. Dighiero, P., Niel, F., Ellies, P., D'Hermies, F., Savoldelli, M., Renard, G., Delpech, M. and Valleix, S. (2001) Histologic phenotype-genotype correlation of corneal dystrophies associated with eight distinct mutations in the TGFBI gene. Ophthalmology, 108, 818-823.
38. Niel-Butschi, F., Kantelip, B., Iwaszkiewicz, J., Zoete, V., Boimard, M., Delpech, M., Bourges, J.L., Renard, G., D'Hermies, F., Pisella, P.J. et al. (2011) Genotype-phenotype correlations of TGFBI p.Leu509Pro, p.Leu509Arg, p.Val613Gly, and the allelic association of p.Met502Val-p.Arg555Gln mutations. Mol. Vis., 17, 1192-1202.
39. Chakroun, N., Prigent, S., Dreiss, C.A., Noinville, S., Chapuis, C., Fraternali, F. and Rezaei, H. (2010) The oligomerization properties of prion protein are restricted to the H2H3 domain. FASEB J., 24, 3222-3231.
40. Sajnani, G., Pastrana, M.A., Dynin, I., Onisko, B. and Requena, J.R. (2008) Scrapie prion protein structural constraints obtained by limited proteolysis and mass spectrometry. J. Mol. Biol., 382, 88-98.
41. Fioriti, L., Angeretti, N., Colombo, L., De Luigi, A., Colombo, A., Manzoni, C., Morbin, M., Tagliavini, F., Salmona, M., Chiesa, R. et al. (2007) Neurotoxic and gliotrophic activity of a synthetic peptide homologous to Gerstmann-Straussler-Scheinker disease amyloid protein. J. Neurosci., 27, 1576-1583.
42. Bate, C., Tayebi, M., Diomede, L., Salmona, M. and Williams, A. (2009) Glimepiride reduces the expression of PrPc, prevents PrPSc formation and protects against prion mediated neurotoxicity in cell lines. PLoS One, 4, e8221.
43. Privat, N., Laffont-Proust, I., Faucheux, B.A., Sazdovitch, V., Frobert, Y., Laplanche, J.L., Grassi, J., Hauw, J.J. and Haik, S. (2008) Human prion diseases: from antibody screening to a standardized fast immunodiagnosis using automation. Mod. Pathol., 21, 140-149.
44. Beringue, V., Le Dur, A., Tixador, P., Reine, F., Lepourry, L., Perret-Liaudet, A., Haik, S., Vilotte, J.L., Fontes, M. and Laude, H. (2008) Prominent and persistent extraneural infection in human PrP transgenic mice infected with variant CJD. PLoS One, 3, e1419.
45. Levavasseur, E., Laffont-Proust, I., Morain, E., Faucheux, B.A., Privat, N., Peoc'h, K., Sazdovitch, V., Brandel, J.P., Hauw, J.J. and Haik, S. (2008) Regulating factors of PrP glycosylation in Creutzfeldt-Jakob disease-implications for the dissemination and the diagnosis of human prion strains. PLoS One, 3, e2786.
46. Rezaei, H., Marc, D., Choiset, Y., Takahashi, M., Hui Bon Hoa, G., Haertle, T., Grosclaude, J. and Debey, P. (2000) High yield purification and physico-chemical properties of full-length recombinant allelic variants of sheep prion protein linked to scrapie susceptibility. Eur. J. Biochem., 267, 2833-2839.
47. Berendsen, H.J.C., van der Spoel, D. and van Drunen, R. (1995) GROMACS: a message-passing parallel molecular dynamics implementation. Comput. Phys. Commun., 91, 43-56.
48. De Simone, A., Zagari, A. and Derreumaux, P. (2007) Structural and hydration properties of the partially unfolded states of the prion protein. Biophys. J., 93, 1284-1292.
49. Telling, G.C., Scott, M., Mastrianni, J., Gabizon, R., Torchia, M., Cohen, F.E., DeArmond, S.J. and Prusiner, S.B. (1995) Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein. Cell, 83, 79-90.
50. Saa, P., Castilla, J. and Soto, C. (2006) Ultra-efficient replication of infectious prions by automated protein misfolding cyclic amplification. J. Biol. Chem., 281, 35245-35252.